This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of REVATIO 20 MG TABLET 90S, a pharmaceutical product, to the U.S. government. The contract, valued at $17,132.93, is a Delivery Order with a Firm Fixed Price pricing type. The awarding agency is the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Revatio 20 mg tablets. The contract, valued at $71,482.39, is a delivery order placed by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract has an ultimate completion date of June 6, 2024 and is a firm fixed-price contract. The contract does not have a set-aside designation, indicating it was competitively awarded....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division involves the delivery of REVATIO 20 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract is a firm-fixed price Delivery Order with a ceiling value of $5,712.08 and an ultimate completion date of May 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $4,670.00 delivery order contract is for the supply of REVATIO 20 MG TABLET 90S, a pharmaceutical product. The contract is a Firm Fixed Price arrangement with a performance period through May 13, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order with a ceiling value of $24,652.98 and a period of performance through May 2024. The award was made by the Defense Logistics Agency (DLA) and is not designated as a set-aside. The contract covers the delivery of REVATIO 20 MG TABLET 90S, a pharmaceutical product used for cardiovascular health treatment. Amerisourcebergen is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of REVATIO 20 MG TABLET 90S, a pharmaceutical product. The firm-fixed-price contract has a ceiling value of $12,629.20 and an ultimate completion date of August 20, 2024. The contract is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery contracts to provide a wide range of...
This is a $7,818.91 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of REVATIO 20 MG TABLET 90S. The contract is a firm-fixed-price arrangement with an ultimate completion date of August 1, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $43,742.55, is for the delivery of REVATIO 20 MG tablets. The contract has an ultimate completion date of June 25, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 90 tablets of the drug REVATIO 20 mg, with a ceiling value of $3,227.37 and a completion date of January 13, 2025. This is a firm fixed-price delivery order contract. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award, valued at $22,344.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order contract for REVATIO 20 MG TABLET 90S, a medication used to treat pulmonary arterial hypertension. The contract has a firm fixed-price pricing type and an ultimate completion date of January 14, 2025. Amerisourcebergen holds a significant Indefinite Delivery...